The PAN Foundation today opened a new patient assistance program for people living with Waldenstrom macroglobulinemia, a rare type of blood cancer that originates in the lymphatic system and is ... Seeking Alpha: Cellectar Biosciences Partners with Florida Cancer Specialists & Research Institute to Support the Treatment of Waldenstrom's Macroglobulinemia in the Community Setting Cellectar Biosciences Partners with Florida Cancer Specialists & Research Institute to Support the Treatment of Waldenstrom's Macroglobulinemia in the Community Setting Seeking Alpha: Iopofosine I 131 Featured in Two Separate Presentations at 12th International Workshop on Waldenstrom’s Macroglobulinemia Iopofosine I 131 Featured in Two Separate Presentations at 12th International Workshop on Waldenstrom’s Macroglobulinemia Iopofosine I 131 achieved an 80% response rate in relapsed/refractory Waldenstrom’s macroglobulinemia, with 56.4% achieving a major response, surpassing the trial's primary goal. The disease control ...
Cure Today: The PAN Foundation Opens New Waldenstrom Macroglobulinemia Patient Assistance Fund Business Insider: Cellectar Biosciences’ Iopofosine I 131 Exceeds Primary Endpoint in Waldenstrom’s Macroglobulinemia Pivotal Study with 78% of Major Response Patients Remaining Progression ... Cellectar Biosciences’ Iopofosine I 131 Exceeds Primary Endpoint in Waldenstrom’s Macroglobulinemia Pivotal Study with 78% of Major Response Patients Remaining Progression ... Yahoo: 'Golden Bachelor' Gerry Turner reveals cancer diagnosis. What is Waldenström's macroglobulinemia?
